Back to Agenda
Models of Collaborations to Advance Regulatory Science: Lessons Learned
Session Chair(s)
Huong Huynh, PHD
Director of Regulatory Science
Critical Path Institute, United States
Regulatory science is a rapidly evolving field with emerging technologies. This session explores collaborative models in drug development and highlights lessons-learned and factors for effective collaborations in advancing regulatory science.
Learning Objective : Discuss models and management of collaborative partnerships to advance novel therapies for patients; Describe strategies to help optimize cross-functional team engagement and multidisciplinary interactions.
Speaker(s)
Panelist
Liang Zhao, PHD
University of California San Francisco, United States
Professor and Director for Center of Global Regulatory Science and Innovation
Panelist
Carla Rodriguez-Watson, PHD, MPH
Reagan-Udall Foundation for the FDA, United States
Director of Research
Panelist
Allison Cuff Shimooka, MBA
TransCelerate Biopharma Inc, United States
Chief Operating Officer
Panelist
Meghana Chalasani, MHA
FDA, United States
Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
Have an account?